Search Login Register

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Summary

Description: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.

Also Known As: MPTP; N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Pyridine, 1,2,3,6-tetrahydro-1-methyl-4-phenyl-

Networked: 2576 relevant articles (118 outcomes, 385 trials/studies) for this Bio-Agent

Key Diseases for which 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine is Relevant

  1. Parkinson Disease (Parkinson's Disease) : 52 outcomes 197 studies in 1272 results
  2. Parkinsonian Disorders (Parkinsonism) : 14 outcomes 72 studies in 642 results
  3. Dyskinesias (Dyskinesia) : 10 outcomes 39 studies in 204 results
  4. Ischemia : 8 outcomes 10 studies in 99 results
  5. Reperfusion Injury : 5 outcomes 10 studies in 81 results
Show All >>

Drugs Related to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

  1. 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
  2. Dopamine (Intropin)
  3. Levodopa (L Dopa)
  4. 1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)
  5. mitochondrial permeability transition pore
  6. Neurotoxins
  7. Selegiline (E250)
  8. Monoamine Oxidase (MAO)
  9. Caffeine (No Doz)
  10. pioglitazone (Actos)
Show All >>

Therapies Related to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

  1. Aftercare (After-Treatment)
  2. Injections
  3. Transplantation (Transplant Recipients)
  4. Denervation
  5. Acupuncture Points (Acupuncture Point)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.